Pharmaceutical compounds as cytotoxic agents and the use thereof

Details for Australian Patent Application No. 2009268547 (hide)

Owner Myriad Pharmaceuticals, Inc.

Inventors Anderson, Mark B.; Kim, In Chul

Agent Peter Maxwell & Associates

Pub. Number AU-A-2009268547

PCT Pub. Number WO2010/006115

Priority 61/079,887 11.07.08 US

Filing date 9 July 2009

Wipo publication date 14 January 2010

International Classifications

A01N 43/54 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/006115 Priority application(s): WO2010/006115

15 December 2011 Alteration of Name

  The name of the applicant has been altered to Myrexis, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009268549-Cyclosporin derivatives for treating ocular and dermal diseases and conditions

2009268539-Semiconductor devices with nonpunch-through semiconductor channels having enhanced conduction and methods of making